No Data
No Data
ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Ars Pharmaceuticals Insider Sold Shares Worth $657,625, According to a Recent SEC Filing
ARS Pharmaceuticals Files for Approval of Neffy in China, Japan and Australia
Express News | ARS Pharmaceuticals Files For Approval Of Neffy In China, Japan And Australia
Express News | Form 144 | ARS Pharmaceuticals(SPRY.US) Officer Proposes to Sell 4.02 Million in Common Stocks
ARS Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)
No Data